™Your Policy Risk Impact Agent
97 chapters · 684 sections in this title.
N.D.C.C. § 23-48-01 Definitions
3.7K chars
As used in this chapter, unless the context otherwise requires: 1. a. "Eligible patient" means an individual who: (1) Has a terminal illness that is attested to by the patient's treating physician; (2) Considered all other treatment options currently approved by the United States…
N.D.C.C. § 23-48-02 Drug manufacturers - Availability of investigational drugs, biological products, or devices - Costs - Insurance coverage
0.9K chars
1. A manufacturer of an investigational drug, biological product, or device may make available the manufacturer's investigational drug, biological product, or device to an eligible patient pursuant to this chapter. This chapter does not require that a manufacturer make available …
N.D.C.C. § 23-48-03 Action against health care provider's license or Medicare certification prohibited
0.6K chars
Notwithstanding any other law, a licensing board may not revoke, fail to renew, suspend, or take any action against a health care provider's license issued in this state, based solely on the health care provider's recommendations to an eligible patient regarding access to or trea…
N.D.C.C. § 23-48-04 Access to investigational drugs, biological products, and devices
0.5K chars
An official, employee, or agent of this state may not block or attempt to block an eligible patient's access to an investigational drug, biological product, or device. Counseling, advice, or a recommendation consistent with medical standards of care from a licensed health care pr…
